Validation of a brand new point of care device and its impact on service
Brad Dickinson, Chief Biomedical Scientist, Leeds Anticoagulant Service, St James’ Hospital

An evaluation of the Blackpool Victoria hospital initiation of warfarin for DVT
Sean O’Brien, Biomedical Scientist, Blackpool Anticoagulation Dosing Advisory Service (ADAS)

Atrial fibrillation and stroke insights tool
Andi Orlowski, Programme Development Lead, Greater Manchester Academic Health Sciences Network (AHSN)

Improving adherence in patients on direct oral anticoagulants (DOACs)
Bunis Packham, Nurse Consultant, Royal Free London Hospital

ORANGE Study: Bleeding on oral anticoagulants (OACs)
Dr Peter MacCallum, Consultant Haematologist, St Bartholomew’s Hospital

Monitoring adherence against the updated NICE guidance on atrial fibrillation (AF)
Dr Campbell Cowan, Cardiologist, Leeds Teaching Hospitals NHS Trust

Warfarin as a new anticoagulant – improving stability and outcome of warfarin by monitoring factors II and X only
Dr Pàll Önundarson, MD, Landspitali Hospital, Iceland

Point of care standards – moving from Wet Prep to Coaguchek
Beverley Straker-Bennet, POCT Lead, Blackpool Anticoagulation Dosing Advisory Service (ADAS)

What use is the DAWN VTE module?
Dr Jane Strong, Consultant Haematologist, University Hospitals of Leicester NHS Trust

Taking on another hospital’s patients and undergoing a process of tendering
Amanda Brailsford, Anticoagulation Service Manager & Sandra Butters, Anticoagulation Nurse, University Hospital of North Midlands

The pitfalls of ‘Any Qualified Provider’ (AQP)
Joanne Malpass, Anticoagulation Services Manager & Rachel Clarke, Anticoagulation Services Deputy Manager, Sandwell & West Birmingham Hospitals NHS Trust

DAWN AC: customer resources; benchmarking; product updates
Melissa Blanchard, Jenny Wood & George Kitching, 4S DAWN Clinical Software